Abstract
Chromosomal region 11p15.5 shows frequent maternal allelic loss in embryonal tumors, including rhabdomyosarcoma (RMS), Wilms' tumor (WT) and hepatoblastoma (HB), consistent with the presence of at least one tumor suppressor gene in this region, which should be paternally imprinted, i.e., expressed from the maternal allele only. The BWR1A gene encodes a polyspecific transmembrane transporter and is located on 11p15.5. It is highly expressed in liver, paternally imprinted and was found to be mutated in an RMS cell line, making it a plausible tumor suppressor gene for HB. We therefore screened 62 HBs, 3 HB cell lines and 1 pediatric hepatocellular carcinoma for BWR1A mutations using single-strand conformation polymorphism analysis. Allelic loss on 11p15.5 was assessed by PCR-based microsatellite analysis in 56 of the cases for which constitutional DNA was available. BWR1A mRNA expression was determined in 14 HBs by differential RT-PCR of matched cDNA samples from tumor and normal liver. Western blot analysis was performed on 4 tumors and matching normal liver tissue. Except for sequence polymorphisms (in exons 2, 3 and 10 as well as in introns 6 and 7), no mutations were found. Thirteen HBs (23%) had allelic loss on 11p15.5; this ...Continue Reading
References
Dec 6, 1979·Nature·D P AdenB B Knowles
Feb 1, 1984·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J L CordellD Y Mason
Jun 1, 1983·Human Pathology·A G Weinberg, M J Finegold
May 4, 1995·Nature·P A LeightonS M Tilghman
Oct 21, 1993·Nature·Y HaoB Tycko
Mar 15, 1995·Genes & Development·M H LeeJ Massagué
Mar 15, 1995·Genes & Development·S MatsuokaS J Elledge
Feb 1, 1995·Urology·I ArielA Hochberg
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·G Bepler, M A Garcia-Blanco
Jun 1, 1996·Human Molecular Genetics·I HatadaT Mukai
Oct 1, 1996·Nature Genetics·I HatadaT Mukai
Aug 1, 1996·Human Molecular Genetics·W Y ChungB Tycko
Sep 1, 1996·Genes, Chromosomes & Cancer·M L OverallP J Smith
Feb 1, 1997·Acta Neuropathologica·T PietschO D Wiestler
Mar 13, 1997·Oncogene·T TaniguchiA E Reeve
Aug 1, 1997·American Journal of Human Genetics·M P LeeA P Feinberg
May 16, 1998·Human Molecular Genetics·D DaoB Tycko
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·C SchwienbacherM Negrini
May 8, 1998·Genomics·P R CooperM J Higgins
Mar 18, 1999·The American Journal of Pathology·J G FallsR L Jirtle
Aug 10, 2000·The American Journal of Pathology·R G WeberP Lichter
Oct 6, 2000·The American Journal of Pathology·W HartmannT Pietsch
Citations
Nov 30, 2005·Oncogene·H Y Yamada, G J Gorbsky
Mar 22, 2013·Journal of Translational Medicine·Sheng-Hua ChuPu-Cha Jiang
Sep 23, 2011·Journal of Translational Medicine·Sheng-Hua ChuPu-Cha Jiang
Mar 20, 2012·Molecular Medicine Reports·Fuliang TianShukui Wang
Feb 1, 2014·Cancer Gene Therapy·S-H ChuJ-M Zhao
Dec 14, 2011·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Sheng-Hua ChuPu-Cha Jiang
Nov 11, 2008·Gene·Abdullah Mahmood AliArun Kumar
Jun 29, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Arthur Zimmermann
Apr 21, 2006·Genomics·E GallagherA Mc Cann
Nov 27, 2008·British Journal of Cancer·S HondaY Kaneko
Mar 3, 2006·American Journal of Epidemiology·Colleen C McLaughlinMichael S Zdeb
Jul 22, 2015·Oncotarget·Yeonjoo JungJaesang Kim
Aug 25, 2018·Cancer Gene Therapy·Biao YangSheng-Hua Chu
Jan 13, 2019·Pharmaceutical Research·Shingo ItoSumio Ohtsuki
Aug 1, 2012·Oncology Letters·Sheng-Hua ChuZhi-An Zhu